Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nuohua (Beijing Nuohua Investment Management) is a leading healthcare-focused professional service and investment platform based in China. Founded in 2010, the company provides a comprehensive suite of services to pharmaceutical and biotech companies, including market access, medical affairs, clinical research (CRO), and commercialization strategies. Additionally, through its investment arm, Nuohua Capital, the firm invests in innovative healthcare startups and manages healthcare-focused funds. Nuohua acts as a strategic partner for both multinational corporations entering the Chinese market and domestic firms seeking to scale their operations. The company is recognized for its deep expertise in the Chinese regulatory and commercial landscape and its ability to bridge the gap between global standards and local market needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nuo Hua Investment.